Research letterPerioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: A retrospective study
References (5)
Continuation of medically necessary aspirin and warfarin during cutaneous surgery
Mayo Clin Proc
(2003)- et al.
Complications with new oral anticoagulants dabigatran and rivaroxaban in cutaneous surgery
Dermatol Surg
(2015)
Cited by (16)
Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery
2021, Journal of the American Academy of DermatologyCitation Excerpt :A more recent retrospective analysis by Eilers et al2 investigated 1800 patients taking any form of oral anticoagulation while undergoing dermatologic surgery and demonstrated a 7-times higher likelihood of postoperative bleeding complications in patients taking DOACs compared with all other anticoagulation types combined.28 Despite the increased risk of bleeding complications with DOAC continuation, the authors of these studies recommended perioperative continuation of DOACs in dermatologic surgery, in accordance with existing dermatologic guidelines regarding other antithrombotic agents such as warfarin, aspirin, and clopidogrel.27-30 Historically, the risk of serious thrombotic events associated with perioperative interruption of warfarin or antiplatelet regimens during dermatologic surgery has been thought to outweigh the risk of limited harm (ie, bleeding complications) with their continuation.31-36
Direct-acting Oral Anticoagulants in Dermatologic Surgery
2020, Actas Dermo-SifiliograficasOptimizing Patient Safety in Dermatologic Surgery
2019, Dermatologic ClinicsCitation Excerpt :A separate study on rivaroxaban reported the benefit of continuing antithrombotic therapy with the caveat of a likely increased risk with complex flap closures.43 A more recent study involving dabigatran, apixaban, and rivaroxaban reported only occasional mild bleeding complications but showed no significant difference in poor outcomes between older and newer anticoagulants.44 However, many of the recent studies on new oral anticoagulants have small sample sizes, and further evaluation is warranted.
Direct oral anticoagulants in skin surgery: a systematic review of their complications and recommendations for perioperative management
2024, International Journal of DermatologyReview of infection and bleeding complications in excisional skin surgery
2024, Clinical and Experimental DermatologyEvidence-Based Performance Measures for Reconstruction after Skin Cancer Resection: A Multidisciplinary Performance Measure Set
2024, Plastic and Reconstructive Surgery
Funding sources: None.
Conflicts of interest: None declared.
Reprints not available from the authors.